Gynecologic Cancer Learning Center CME/CE

• 10.50 90.50 20.50 30.50
  Obstacles and Opportunities: How Do We Increase Adult Immunization Rates?
  Medscape Education Family Medicine April 11, 2022
  Our experts brainstorm about strategies for overcoming challenges/barriers to increasing vaccination rates among adults.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN 0.50 CEMIN

  
  Save
• 10.50 90.50
  The State of Therapeutics in GYN Cancers: Where Are We Headed?
  Medscape Education Oncology April 07, 2022
  Did you know that practice changing therapeutics are expected to be approved soon for use in GYN cancers?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50
  The Afternoon Show in Gynecologic Oncology: The Evolution of Cervical Cancer
  Medscape Education Oncology April 06, 2022
  ​This activity is intended for oncology specialists, obstetrics/gynecologists, nurse practitioners, and physician assistants.
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.75
  From the Biomarker Lens: Poly(ADP-Ribose) Polymerase Inhibitor Implementation in Ovarian Cancer
  Medscape Education Oncology February 28, 2022
  The faculty discuss key biomarkers used to guide treatment with PARP inhibitors in the advanced ovarian cancer setting.
  
  0.75 CMEMIN

  
  Save
• 11.00 91.00
  Biomarkers in Ovarian Cancer: Virtual Patient Case Simulations
  Medscape Education Oncology January 21, 2022
  Review clinical decision-making for optimal care of patients with advanced ovarian cancer
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• 10.50 90.50
  Ongoing Progress in the Management of Metastatic Cervical Cancer
  Medscape Education Oncology January 04, 2022
  Join the faculty for a discussion on the latest clinical data and advances in the treatment paradigm of metastatic cervical cancer.
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 11.00 81.00
  HE4: A Novel Serum Biomarker for Monitoring and Managing Epithelial Ovarian Cancer
  December 15, 2021
  Learn the clinical utility of the underutilized novel serum biomarker human epididymis 4 (HE4) and understand its importance in monitoring and managing epithelial ovarian cancer.
  
  1.00 CMEMIN 1.00 CEMIN

  
  Save
• 30.50
  A Pharmacist Forum: Value-Based Clinical Management of Ovarian Cancer With PARP Inhibitors
  Medscape Education Oncology November 18, 2021
  An expert panel of pharmacists discuss the value-based clinical management of ovarian cancer with PARP inhibitors.
  
  0.50 CEMIN

  
  Save
• 12.00 92.00 22.00
  Turning Negative Into Positives in TNBC
  Medscape Education Oncology November 02, 2021
  
  2.00 CME/CEMIN 2.00 ABIM MOCMIN 2.00 CEMIN

  
  Save
• 13.00 93.00 23.00 33.00
  Sexually Transmitted Infections Treatment Guidelines, 2021
  Morbidity & Mortality Weekly Report October 27, 2021
  The CDC updated 2015 STI guidelines to assist physicians and other HCPs in STI treatment, prevention strategies, diagnosis, and counseling.
  
  3.00 CME/CEMIN 3.00 ABIM MOCMIN 3.00 CEMIN 3.00 CEMIN

  
  Save
• 10.75 90.75
  Investigating Cervical Cancer: A Review of Key Data From the Annual European Oncology Meeting
  Medscape Education Oncology October 12, 2021
  Get the latest information on cervical cancer from leading experts!
  
  0.75 CMEMIN 0.75 ABIM MOCMIN

  
  Save
• 10.50 90.50 30.50
  A Value-Based Framework in the Clinical Integration of PARP Inhibitors in the Management of Ovarian Cancer
  Medscape Education Oncology October 04, 2021
  Three experts discuss the role of PARP inhibitors in clinical practice and the role of the managed care pharmacist in coordinating care.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save
• 10.50 20.50
  Racial and Ethnic Disparities in Breastfeeding Initiation — United States, 2019
  Morbidity & Mortality Weekly Report October 01, 2021
  State/territory-specific data highlight variation in breastfeeding disparities across the United States, which may help identify groups to target with breastfeeding promotion programs.
  
  0.50 CME/CEMIN 0.50 CEMIN

  
  Save
• The Diagnostic Journey of Patients With Suspected Cancer: Where Are We Now, and Where Are We Going?
  Medscape Education Gastroenterology September 21, 2021
  Experts discuss the risks and symptoms to look out for in patients with suspected cancer.
  
  
  Save
• 12.50 92.50 22.50 32.50
  Surveillance of Vaccination Coverage Among Adult Populations — United States, 2018
  Morbidity & Mortality Weekly Report September 15, 2021
  Many US adults are unprotected against vaccine-preventable diseases, with modest gains from 2017 to 2018 in coverage for HBV and HPV.
  
  2.50 CME/CEMIN 2.50 ABIM MOCMIN 2.50 CEMIN 2.50 CEMIN

  
  Save
• 10.25 90.25
  Human Papillomavirus and Cervical Cancer: Extended Genotyping and Risk-Based Management Strategies
  Medscape Education Ob/Gyn & Women's Health August 26, 2021
  Learn how cervical cancer screening is evolving with HPV testing and genotyping.
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.75 90.75
  Advanced TNBC: Targets and Therapies Poised to Improve Outcomes 
  Medscape Education Oncology August 19, 2021
  Join this expert panel as they discuss the latest mid-year data on the treatment of advanced triple-negative breast cancer.
  
  0.75 CMEMIN 0.75 ABIM MOCMIN

  
  Save
• 10.25 90.25 20.25
  Communication Conundrums: Tips and Techniques for Addressing Questions About HPV Immunization
  Medscape Education Infectious Diseases August 18, 2021
  Join Drs Alexander and Park for a quickfire exchange on effective strategies for tackling challenging questions about HPV vaccination.
  
  0.25 CME/CEMIN 0.25 ABIM MOCMIN 0.25 CEMIN

  
  Save
• 20.50
  The Nurse View: PARP Implementation in Ovarian Cancer
  Medscape Education Nurses June 25, 2021
  Two experts discuss the nursing perspective of implementing PARP inhibitors into the care of patients with ovarian cancer.
  
  0.50 CEMIN

  
  Save
• Breaking Down the Data on Cancer Detection: Updates for the Primary Care Team
  Medscape Education Oncology June 25, 2021
  Join the experts for a discussion on the use of emerging multi-cancer detection technology in the clinic.
  
  
  Save